RecruitingNot Applicable

Atomized Inhalation ICG for Treatment of Congenital Lung Malformations

China50 participantsStarted 2024-03-01

Plain-language summary

To investigate the safety and effectiveness of preoperative aerosol inhalation ICG solution for thoracoscopic accurate resection of congenital lung malformations in children.

Who can participate

Age range3 Months – 14 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * children with congenital lung malformations diagnosed by CT or MRI scan Exclusion Criteria: * 1\. ages \<3 months and \>14 years 2. complicated other life-threatening disease; 3. complicated severely pulmonary infection

What they're measuring

rate residual

Timeframe: 3 months

Trial details

NCT IDNCT06302985

SponsorJiexiong Feng

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2050-12-31

Contact for this trial

Tianqi Zhu, MD

0086-13986295423 zhutianqi84@163.com

View on ClinicalTrials.gov More Pulmonary Sequestration trials